222 related articles for article (PubMed ID: 23716537)
1. CD30 expression in peripheral T-cell lymphomas.
Sabattini E; Pizzi M; Tabanelli V; Baldin P; Sacchetti CS; Agostinelli C; Zinzani PL; Pileri SA
Haematologica; 2013 Aug; 98(8):e81-2. PubMed ID: 23716537
[No Abstract] [Full Text] [Related]
2. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
3. CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.
Bisig B; de Reyniès A; Bonnet C; Sujobert P; Rickman DS; Marafioti T; Delsol G; Lamant L; Gaulard P; de Leval L
Haematologica; 2013 Aug; 98(8):1250-8. PubMed ID: 23716562
[TBL] [Abstract][Full Text] [Related]
4. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.
de Leval L; Rickman DS; Thielen C; Reynies Ad; Huang YL; Delsol G; Lamant L; Leroy K; Brière J; Molina T; Berger F; Gisselbrecht C; Xerri L; Gaulard P
Blood; 2007 Jun; 109(11):4952-63. PubMed ID: 17284527
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels.
Bossard C; Dobay MP; Parrens M; Lamant L; Missiaglia E; Haioun C; Martin A; Fabiani B; Delarue R; Tournilhac O; Delorenzi M; Gaulard P; de Leval L
Blood; 2014 Nov; 124(19):2983-6. PubMed ID: 25224410
[TBL] [Abstract][Full Text] [Related]
6. BCL-6 protein expression in human peripheral T-cell neoplasms is restricted to CD30+ anaplastic large-cell lymphomas.
Carbone A; Gloghini A; Gaidano G; Dalla-Favera R; Falini B
Blood; 1997 Sep; 90(6):2445-50. PubMed ID: 9310496
[TBL] [Abstract][Full Text] [Related]
7. Peripheral T-cell lymphomas expressing CD30 and CD15.
Barry TS; Jaffe ES; Sorbara L; Raffeld M; Pittaluga S
Am J Surg Pathol; 2003 Dec; 27(12):1513-22. PubMed ID: 14657710
[TBL] [Abstract][Full Text] [Related]
8. Frequent expression of CD30 in extranodal NK/T-cell lymphoma: Potential therapeutic target for anti-CD30 antibody-based therapy.
Kawamoto K; Miyoshi H; Suzuki T; Sasaki Y; Yamada K; Yanagida E; Muto R; Kiryu M; Sone H; Seto M; Ohshima K; Takizawa J
Hematol Oncol; 2018 Feb; 36(1):166-173. PubMed ID: 29052238
[TBL] [Abstract][Full Text] [Related]
9. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
McKelvie PA; Thompson PA; Tam CS
Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
[TBL] [Abstract][Full Text] [Related]
10. Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas.
Uemura Y; Isobe Y; Uchida A; Asano J; Nishio Y; Sakai H; Hoshikawa M; Takagi M; Nakamura N; Miura I
Cancer Sci; 2018 Apr; 109(4):1254-1262. PubMed ID: 29363227
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization.
Karaarslan S; Hekimgil M; Soydan S; Ertan Y; Doğanavşargil B
Pol J Pathol; 2015 Jun; 66(2):161-9. PubMed ID: 26247530
[TBL] [Abstract][Full Text] [Related]
12. Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20.
Song JY; Strom T; Raffeld M; Pittaluga S; Jaffe ES
J Clin Oncol; 2011 Nov; 29(32):e789-91. PubMed ID: 21990402
[No Abstract] [Full Text] [Related]
13. [Analysis of mature T-cell and NK-cell lymphoma with CD30 expression based on latest WHO classification].
Feng Y; Fu J; Yan S; Ling Y; Huang Y; Cai M; Rao H
Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):508-11. PubMed ID: 25346118
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities.
Kim WY; Nam SJ; Kim S; Kim TM; Heo DS; Kim CW; Jeon YK
Leuk Lymphoma; 2015 Jun; 56(6):1778-86. PubMed ID: 25288491
[TBL] [Abstract][Full Text] [Related]
15. CD30 expression in cutaneous B-cell and post-transplant peripheral T-cell lymphoma: report of 2 cases.
Albrecht H; Woodroof JM; Reyes R; Powers BC; Fraga GR
Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046457
[TBL] [Abstract][Full Text] [Related]
16. [Expression of microRNA in ALK-negative anaplastic large cell lymphoma and CD30-positive peripheral T cell lymphoma, not otherwise specified].
Wang C; Chen X; Chen X; He Y; Cao L
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):565-70. PubMed ID: 26705180
[TBL] [Abstract][Full Text] [Related]
17. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
19. Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: a comprehensive clinicopathologic and phenotypic study.
Pongpruttipan T; Sukpanichnant S; Assanasen T; Wannakrairot P; Boonsakan P; Kanoksil W; Kayasut K; Mitarnun W; Khuhapinant A; Bunworasate U; Puavilai T; Bedavanija A; Garcia-Herrera A; Campo E; Cook JR; Choi J; Swerdlow SH
Am J Surg Pathol; 2012 Apr; 36(4):481-99. PubMed ID: 22314189
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic study of 963 cases of mature T-cell and natural killer/T-cell lymphoma with respect to 2008 WHO classification of lymphoid neoplasms].
Liang Q; Ye ZY; Su ZL; Lin HL; Shao CK; Lin SX; Rao HL; Mei KY; Zhao T; Liu YH; Luo DL; Zhu MG; Chen SH; Lin TY
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):291-5. PubMed ID: 20654150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
